Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Thorne HealthTech commercializes a broad portfolio of personalized supplements and diagnostic tests. Its flagship device—OneDraw—has regulatory clearance and adoption in major initiatives such as the U.S. Department of Defense's PROMETHEUS project. The company collaborates with leading institutions like Mayo Clinic and AstraZeneca to advance scientific research in personalized wellness. No traditional pharmaceutical clinical trial results are reported as its focus remains on consumer diagnostics and supplements rather than prescription therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Thorne HealthTech.